BRIEF-Antibe Therapeutics announces pricing of offering
May 26, 2017 at 09:13 AM EDT
* Antibe Therapeutics - to amend preliminary short form prospectus relating to marketed public offering of units for gross proceeds of $3 million to $5 million
